Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Jeschke

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Der Anaesthesist|January 17, 2004
[Intensive insulin therapy in sepsis. Improvement of survival chances?]M G Jeschke
Gene Therapy|February 13, 2004
Liposomal gene transfer of multiple genes is more effective than gene transfer of a single geneM G Jeschke, D Klein
Gene Therapy|June 1, 2007
The combination of IGF-I and KGF cDNA improves dermal and epidermal regeneration by increased VEGF expression and neovascularizationM G Jeschke, D N Herndon
Plastic and Reconstructive Surgery|June 8, 2001
Cultured autologous outer root sheath cells: a new therapeutic alternative for chronic decubitus ulcersM G Jeschke, W Richter, S G Ruf
Cytokine|September 8, 2000
Differential expression of hepatocyte growth factor in liver, kidney, lung, and spleen following burn in ratsY Yamashita, M G Jeschke, S E Wolf
Cellular and Molecular Life Sciences : CMLS|April 10, 2014
Animal models in burn researchA Abdullahi, S Amini-Nik, M G Jeschke
Novartis Foundation Symposium|March 27, 2007
Beta-blockade in burnsC T Pereira, M G Jeschke, D N Herndon
Plastic and Reconstructive Surgery|March 21, 2000
Early release of third-degree eyelid burns prevents eye injuryR E Barrow, M G Jeschke, D N Herndon
Annals of Surgery|February 16, 2000
Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned childrenM G Jeschke, R E Barrow, D N Herndon
Critical Care Medicine|June 2, 2000
Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase responseM G Jeschke, R E Barrow, D N Herndon
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Der Anaesthesist|January 17, 2004
[Intensive insulin therapy in sepsis. Improvement of survival chances?]M G Jeschke
Gene Therapy|February 13, 2004
Liposomal gene transfer of multiple genes is more effective than gene transfer of a single geneM G Jeschke, D Klein
Gene Therapy|June 1, 2007
The combination of IGF-I and KGF cDNA improves dermal and epidermal regeneration by increased VEGF expression and neovascularizationM G Jeschke, D N Herndon
Plastic and Reconstructive Surgery|June 8, 2001
Cultured autologous outer root sheath cells: a new therapeutic alternative for chronic decubitus ulcersM G Jeschke, W Richter, S G Ruf
Cytokine|September 8, 2000
Differential expression of hepatocyte growth factor in liver, kidney, lung, and spleen following burn in ratsY Yamashita, M G Jeschke, S E Wolf
Cellular and Molecular Life Sciences : CMLS|April 10, 2014
Animal models in burn researchA Abdullahi, S Amini-Nik, M G Jeschke
Novartis Foundation Symposium|March 27, 2007
Beta-blockade in burnsC T Pereira, M G Jeschke, D N Herndon
Plastic and Reconstructive Surgery|March 21, 2000
Early release of third-degree eyelid burns prevents eye injuryR E Barrow, M G Jeschke, D N Herndon
Annals of Surgery|February 16, 2000
Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned childrenM G Jeschke, R E Barrow, D N Herndon
Critical Care Medicine|June 2, 2000
Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase responseM G Jeschke, R E Barrow, D N Herndon
Pageof 6